Steven Cohen’s iRadimed IRMD Stock Holding History

Steven Cohen’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Sell	11,909 -2,410	-17%	-$219K	﹤0.01%	2755
2026 Q1	$1.38M	Buy	14,319 +3,337	+30%	+$334K	﹤0.01%	2555
2025 Q4	$1.07M	Sell	10,982 -228	-2%	-$19.6K	﹤0.01%	2836
2025 Q3	$798K	Buy	+11,210	New	+$747K	﹤0.01%	1779
2023 Q3	–	Sell	-502	Closed	-$23.9K	–	2665
2023 Q2	$23.9K	Buy	+502	New	+$22.6K	﹤0.01%	1754
2016 Q1	–	Sell	-100	Closed	-$3K	–	782
2015 Q4	$3K	Buy	+100	New	+$2.83K	﹤0.01%	664

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steven Cohen's IRMD Position: Q2 2026 in Review

Steven Cohen reduced its iRadimed (IRMD) stake by 17% in Q2 2026, selling an estimated $219K and leaving 11,909 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2755.

Steven Cohen first reported a position in IRMD in Q4 2015 and has held it in 6 quarters since. The position peaked at $1.38M in Q1 2026. 212 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Steven Cohen held 11,909 shares of iRadimed worth $1.14M as of Q2 2026.
Steven Cohen sold 2,410 iRadimed shares in Q2 2026, an estimated $219K.
iRadimed made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #2755 holding.
Steven Cohen first reported a position in iRadimed in Q4 2015 and has held it in 6 quarters since.
Steven Cohen's iRadimed position peaked at $1.38M in Q1 2026.
212 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.